Evaluation and Development of a SMI-UI in Prostate Cancer Patients


The following is a summary of “Development and assessment of a self-management intervention for urinary incontinence among patients with prostate cancer: protocol for a randomized feasibility study,” published in the November 2023 issue of Urology by Chien, et al.


For a study, researchers sought to develop and assess the feasibility, acceptability, and effectiveness of a self-management intervention for urinary incontinence (SMI-UI). The intervention comprised a mobile self-management application, a self-management handbook, and professional support. The research design involved a parallel and random assignment, and patient data will be collected from two urology departments through convenience sampling.

Patients who had undergone radical prostatectomy and were experiencing urinary incontinence would be recruited. A pretest questionnaire will be administered, and patients will be randomly assigned to either the experimental group, undergoing a 12-week SMI-UI, or the attention control group, receiving a dietetic education information package. Follow-up assessments will be conducted at 12 and 16 weeks post the pretest.

The study would record sociodemographic and clinical variables, recruitment rate, retention rate, satisfaction with the intervention, cancer-related self-efficacy, urination symptoms and disturbance, social participation and satisfaction, resilience, and demoralization.

The outcomes would provide insights into the feasibility, acceptability, and effectiveness of the SMI-UI intervention in patients with urinary incontinence post-radical prostatectomy. The recorded variables would be analyzed to evaluate the impact of the intervention on various aspects, including patient satisfaction, self-efficacy, urination symptoms, social participation, resilience, and demoralization.

Source: bmcurol.biomedcentral.com/articles/10.1186/s12894-023-01367-7



Source link

Leave A Reply

Your email address will not be published.